Trauma resuscitation is rarely as straightforward as mnemonics suggest. Every ATLS candidate learns, early and often, that the two pillars of haemorrhage management are controlling the source of bleeding and avoiding the over-aggressive fluid replacement that worsens coagulopathy and "pops the clot." This philosophy - broadly described as permissive hypotension or damage control resuscitation - has become so embedded in trauma doctrine that it now feels almost intuitive. Allow the blood pressure to sit lower than normal, tolerate a systolic of around seventy to eighty millimetres of mercury, use blood products rather than crystalloid, and get the patient to a surgeon. The data supporting this approach in penetrating trauma are particularly compelling, stemming from Walter Bickell's landmark 1994 New England Journal of Medicine trial, which showed a survival advantage when fluid resuscitation was deliberately delayed in patients with penetrating torso injuries.
But now imagine that same patient arrives in your resuscitation bay having come off a motorbike at seventy miles per hour. They have a shattered pelvis, a haemothorax, and — visible on your initial assessment — unequal pupils and a GCS of nine. They are bleeding, yes. But they also have a serious traumatic brain injury. The pelvis demands you keep the blood pressure low. The brain demands you keep it high. You cannot fully satisfy both imperatives at once, and your next few decisions will determine whether this patient lives or dies, or — perhaps worse — survives in a severely disabled state. This is the polytrauma blood pressure dilemma, and it remains one of the most genuinely unresolved questions in acute trauma care.
Why the Brain and the Bleeding Wound Have Different Needs
To understand why this conflict is so intractable, it helps to think clearly about what each injury actually requires from haemodynamic management. In the bleeding patient, the harm from aggressive resuscitation comes from multiple directions simultaneously. Raising blood pressure above a critical threshold can mechanically dislodge a newly formed clot, resume haemorrhage, and accelerate blood loss. Large volumes of crystalloid dilute clotting factors and cause dilutional coagulopathy, contributing to the so-called lethal triad of hypothermia, acidosis and coagulopathy that kills exsanguinating patients in the operating theatre. Permissive hypotension mitigates all of these effects by accepting a lower blood pressure as a necessary trade-off to buy time for surgical haemorrhage control.
The injured brain operates on an entirely different physiological logic. Under normal circumstances, the brain autoregulates its own blood supply across a wide range of systemic blood pressures, maintaining cerebral blood flow almost regardless of what is happening elsewhere in the circulation. After a significant traumatic brain injury, this autoregulation is impaired or abolished entirely. The brain loses its ability to buffer against fluctuations in systemic pressure, and cerebral blood flow becomes directly - and dangerously - dependent on mean arterial pressure. Drop the systemic blood pressure, and cerebral perfusion falls in lock-step. The result is secondary brain injury: ischaemic neuronal death superimposed on the primary traumatic injury, causing harm that no amount of neurosurgical expertise can subsequently reverse.
The scale of this secondary injury problem is substantial. A 2024 narrative review published in Neurocritical Care, drawing on a cohort of over twelve thousand adult TBI patients, found that mortality was 9.2% in patients who sustained no hypotension, 27.8% in those who experienced hypotension only in the prehospital phase, 45.6% in those who first became hypotensive in the emergency department, and over 55% in patients who experienced hypotension in both settings. Each hypotensive episode, however brief, compounds the injury. The brain does not forgive even temporary ischaemia.
Moving the Goalposts: How the Targets Have Changed
For much of the ATLS era, the threshold defining hypotension in TBI was a systolic blood pressure below ninety millimetres of mercury. This number had a certain symmetry with the haemorrhagic shock literature, where SBP below ninety served as the key trigger for aggressive resuscitation. But the neurotrauma community increasingly viewed this threshold as dangerously low. Work by Berry and colleagues, published in the Journal of Neurotrauma, analysed over fifteen thousand patients with TBI and found that adverse outcomes were associated with systolic pressures below 110 mmHg in patients aged fifteen to forty-nine and over seventy, and below 100 mmHg in those aged fifty to sixty-nine. These age-stratified thresholds were subsequently adopted by the Brain Trauma Foundation and, crucially, by the American College of Surgeons TBI guidelines published in 2024, which formally recommended targeting a systolic blood pressure above 110 millimetres of mercury in most adult TBI patients.
The implications for ATLS practice are significant. The gap between what the bleeding patient "wants" (SBP in the region of seventy to eighty) and what the brain-injured patient "needs" (SBP above one hundred and ten) is now forty millimetres of mercury or more. These two targets are not merely different - they are physiologically incompatible in the same patient at the same time. Closing that gap requires either accepting ongoing intracranial ischaemia or accepting continued haemorrhage, and neither is a satisfactory answer.
The Hidden Complexity: When the Brain Itself Causes Shock
Matters are complicated further by a phenomenon that has received increasing attention in the trauma literature: brain injury associated shock, or BIAS. It has long been recognised that severe TBI, particularly diffuse injuries with high intracranial pressure, can trigger a catecholamine storm that paradoxically causes cardiovascular instability - manifesting as tachycardia, hypotension and poor peripheral perfusion. A 2024 study published in Prehospital Emergency Care and led by Partyka and colleagues examined over twelve hundred intubated trauma patients and found that the haemodynamic presentations of BIAS and conventional haemorrhagic shock were essentially indistinguishable in the prehospital environment. Both caused similar levels of tachycardia, hypotension and elevated shock index. Both received similar prehospital interventions. And yet their ideal treatment strategies point in opposite directions: haemorrhagic shock demands volume replacement and blood products, while BIAS may respond better to vasopressors and efforts to reduce intracranial pressure.
The practical implication of this finding is sobering: the prehospital clinician or emergency physician who encounters a hypotensive, unconscious trauma patient may not be able to determine - at least initially - whether they are dealing primarily with haemorrhage, a neurogenic cardiovascular response to brain injury, or both simultaneously. The algorithms that ATLS teaches are predicated on being able to identify the problem before treating it, but in the polytrauma setting, the diagnosis may arrive too late to guide the first critical decisions.
The ATLS 11th Edition and the 2024 Resuscitation Paradigm
The publication of the ATLS 11th Edition in 2025 reflects how seriously the trauma community has grappled with exactly these tensions. The most significant conceptual change - the move from ABCDE to xABCDE, where the "x" represents exsanguinating haemorrhage control - signals an acknowledgement that catastrophic bleeding must be addressed even before airway management in certain patients. A multicenter international trial led by Ferrada and published in the World Journal of Emergency Surgery in 2024 found a 91% reduction in the odds of 24-hour mortality when circulation-first (CAB) sequencing was used rather than the traditional airway-first approach in massively haemorrhaging patients. This is a dramatic finding and a significant cultural shift for a curriculum that has placed "A" first for four decades.
The 11th edition also integrates more nuanced guidance on the TBI-haemorrhage conflict, acknowledging the need for individualised blood pressure targets rather than a single universal figure. But nuanced guidance and clinical reality in a busy resuscitation bay are different things. When a team of three is simultaneously managing an airway, establishing massive transfusion protocol and placing a pelvic binder, the luxury of individualised haemodynamic titration is not always available.
The TRAIN trial, published in JAMA in 2024, adds another layer of complexity relevant to the TBI side of this equation. The trial examined transfusion thresholds in patients with acute brain injury and found that a liberal transfusion strategy - giving blood to maintain haemoglobin above nine grams per decilitre rather than the traditional restrictive threshold of seven - significantly improved neurological outcomes, with a number needed to treat of approximately ten. This finding challenges the almost universal adoption of restrictive transfusion targets in critical care and suggests that, in the brain-injured patient, the costs of anaemia may have been systematically underestimated. Applied to the polytrauma setting, it reinforces the view that blood products - rather than crystalloid - are the right resuscitation fluid, since they address haemorrhage control, coagulopathy, and cerebral oxygen delivery simultaneously.
What This Means for ATLS Candidates and Clinicians
The blood pressure dilemma in polytrauma with TBI represents one of the most intellectually honest challenges in modern ATLS teaching, precisely because there is no clean algorithmic solution. ATLS has always been strongest when its protocols reflect genuine evidence and acknowledge genuine uncertainty; it is weakest when it implies that every clinical situation can be resolved by following a flow diagram.
The practical framework that most authorities now converge on holds the following positions. Permissive hypotension should not be used in patients with known or suspected TBI - the 2024 ACS TBI guidelines are explicit on this point. Where both haemorrhage and TBI coexist, the priority should be aggressive haemorrhage control as rapidly as possible, so that blood pressure can be normalised without the penalty of worsening haemorrhage. This is the principle that underpins the xABCDE philosophy: stop the bleeding first, because only once the bleeding is stopped can you safely give the blood pressure the brain requires. Early massive transfusion protocol activation, early surgical haemorrhage control - whether through interventional radiology, pelvic packing or laparotomy - and the judicious use of vasopressors as a bridge to definitive surgery represent the current state of the art in managing this difficult scenario.
What candidates should take away from this controversy is not a new number to memorise but a deeper appreciation of why the numbers matter. A systolic blood pressure of eighty millimetres of mercury is not just a number - in the context of an isolated solid organ injury, it may represent appropriate damage control resuscitation; in the context of a subdural haematoma, it may represent an episode of secondary brain injury that will manifest as disability or death weeks later. The same clinical observation carries entirely different implications depending on the context in which it occurs. This is the kind of nuanced thinking that distinguishes an excellent trauma clinician from one who is simply following a protocol, and it is, ultimately, what the best ATLS teaching has always tried to develop.